Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Magnesium Sulfate in Nasal Endoscopic Surgery
NCT06920576Phase 2Active, not recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Mar 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esketamine, magnesium sulfate in postoperative pain, anxiety disorder, major depressive disorder (MDD), sponsored by Huai'an Second Hospital. Started Mar 2025; status: active, not recruiting.
02
Drugs
esketaminemagnesium sulfate
03
Conditions
postoperative painanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06920576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06920576.